Concepedia

C J Boylan

CJ

Statistics

Publications

5

Citations

416

H-Index

5

Active since

1992

Affiliations

Eli Lilly (United States)(Current)

C J Boylan is an author at Eli Lilly (United States) specializing in pharmacology, pneumocystis infection, and antimicrobial pharmacology.

Publications per year

1992–2003

5

Publications

5

Validation of a Noninvasive, Real-Time Imaging Technology Using Bioluminescent <i>Escherichia coli</i> in the Neutropenic Mouse Thigh Model of Infection

Heather L. Rocchetta, C J Boylan, Joseph W. Foley et al. · Antimicrobial Agents and Chemotherapy · 2001 · 147 citations · Full text

, , +17

Pharmacodynamics of Oritavancin (LY333328) in a Neutropenic-Mouse Thigh Model of <i>Staphylococcus aureus</i> Infection

C J Boylan, Kristina Campanale, Philip W. Iversen et al. · Antimicrobial Agents and Chemotherapy · 2003 · 79 citations · Full text

, , +15

Improved rat model of Pneumocystis carinii pneumonia: induced laboratory infections in Pneumocystis-free animals

C J Boylan, William L. Current · Infection and Immunity · 1992 · 72 citations · Full text

, , +15

4-Substituted <scp>d</scp>-Glutamic Acid Analogues:  The First Potent Inhibitors of Glutamate Racemase (MurI) Enzyme with Antibacterial Activity

Alfonso de Dios, Lourdes Prieto, José A. Martín et al. · Journal of Medicinal Chemistry · 2002 · 60 citations · Full text

, , +17

Semisynthetic echinocandins affect cell wall deposition of Pneumocystis carinii in vitro and in vivo

Marilyn S. Bartlett, William L. Current, Michael P. Goheen et al. · Antimicrobial Agents and Chemotherapy · 1996 · 58 citations · Full text

, , +16

1–5 of 5